JAK2 activation promotes tumorigenesis in ALK-negative anaplastic large cell lymphoma via regulating oncogenic STAT1-PVT1 lncRNA axis

Authors

Kang Le, GW Cancer Center
Linda E. Wellik, Mayo Clinic in Rochester, Minnesota
Matthew J. Maurer, Mayo Clinic in Rochester, Minnesota
Ellen D. McPhail, Mayo Clinic in Rochester, Minnesota
Thomas E. Witzig, Mayo Clinic in Rochester, Minnesota
Mamta Gupta, GW Cancer Center

Document Type

Letter to the Editor

Publication Date

3-1-2021

Journal

Blood Cancer Journal

Volume

11

Issue

3

DOI

10.1038/s41408-021-00447-x

APA Citation

Le, K., Wellik, L., Maurer, M., McPhail, E., Witzig, T., & Gupta, M. (2021). JAK2 activation promotes tumorigenesis in ALK-negative anaplastic large cell lymphoma via regulating oncogenic STAT1-PVT1 lncRNA axis. Blood Cancer Journal, 11 (3). http://dx.doi.org/10.1038/s41408-021-00447-x